Study of Fruquintinib (HMPL-013) in High Risk Patients With Advanced NSCLC
Clinical trial NCT03684967 · WITHDRAWN
Trial details
- NCT number
- NCT03684967
- Sponsor
- Hutchison Medipharma Limited
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-08
- Primary completion
- 2019-09-06
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.